In addition, we calculated PSA velocity in 35,140 healthy men and 125 men diagnosed with prostate cancer who underwent multiple tests for more than two years in a row in order to observe PSA velocity fluctuation in both healthy men and men diagnosed with prostate cancer according to age (Figs. S3 and S4). Here, KLK3 is linked to prostate carcinoma.